Correction to: Signal Transduction and Targeted Therapy https://doi.org/10.1038/s41392-020-00289-2, published online 31 August 2020

In the process of collating the raw data, the authors noticed one inadvertent mistake in Fig. 1 that need to be corrected.1 The correct data are provided as follows. The key findings of the article are not affected by these corrections.

Fig. 1j
figure 1

Left Panel: inhibition profiling was tested at the indicated concentrations of ABP with or without exposure to EGF in A549 cells. Right panel: The invasion ability of A549 and PC-9 cells in untreated, EGF (20 ng/mL) treated, and EGF (20 ng/mL) plus indicated concentrations of ABP-treated groups was assessed by transwell analyses

In the right panel of Fig. 1j, the represented image showing the invasion ability of A549 cells in EGF groups was made a mistake when pasted the picture, which is an inadvertent mistake. After checked the original data, the corrected version of the figure is shown below.